These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22246856)

  • 21. Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia.
    Tiacci E; Schiavoni G; Martelli MP; Boveri E; Pacini R; Tabarrini A; Zibellini S; Santi A; Pettirossi V; Fortini E; Ascani S; Arcaini L; Inghirami G; Paulli M; Falini B
    Haematologica; 2013 Apr; 98(4):635-9. PubMed ID: 23349307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phospho-ERK(THR202/Tyr214) is overexpressed in hairy cell leukemia and is a useful diagnostic marker in bone marrow trephine sections.
    Warden DW; Ondrejka S; Lin J; Durkin L; Bodo J; Hsi ED
    Am J Surg Pathol; 2013 Feb; 37(2):305-8. PubMed ID: 23211289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hairy cell leukemia cell lines expressing annexin A1 and displaying B-cell receptor signals characteristic of primary tumor cells lack the signature BRAF mutation to reveal unrepresentative origins.
    Weston-Bell NJ; Hendriks D; Sugiyarto G; Bos NA; Kluin-Nelemans HC; Forconi F; Sahota SS
    Leukemia; 2013 Jan; 27(1):241-5. PubMed ID: 22705994
    [No Abstract]   [Full Text] [Related]  

  • 24. Detection of BRAF V600E mutation in colorectal cancer: comparison of automatic sequencing and real-time chemistry methodology.
    Benlloch S; Payá A; Alenda C; Bessa X; Andreu M; Jover R; Castells A; Llor X; Aranda FI; Massutí B
    J Mol Diagn; 2006 Nov; 8(5):540-3. PubMed ID: 17065421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of concomitant chronic lymphocytic leukaemia and hairy cell leukaemia evaluated for IGHV-D-J rearrangements and BRAF-V600E mutation: lack of evidence for a common origin.
    Cavalli M; Ilari C; Del Giudice I; Marinelli M; Della Starza I; De Propris MS; De Novi LA; Nunes V; Cafforio L; Raponi S; Mancini F; Mauro FR; Tiacci E; Falini B; Guarini A; Foà R
    Br J Haematol; 2016 Jul; 174(2):329-31. PubMed ID: 26455504
    [No Abstract]   [Full Text] [Related]  

  • 26. Somatic BRAF-V600E mutations in familial colorectal cancer.
    Vandrovcova J; Lagerstedt-Robinsson K; Påhlman L; Lindblom A
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2270-3. PubMed ID: 17119056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases.
    Capper D; Berghoff AS; Magerle M; Ilhan A; Wöhrer A; Hackl M; Pichler J; Pusch S; Meyer J; Habel A; Petzelbauer P; Birner P; von Deimling A; Preusser M
    Acta Neuropathol; 2012 Feb; 123(2):223-33. PubMed ID: 22012135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo.
    Ouyang B; Knauf JA; Smith EP; Zhang L; Ramsey T; Yusuff N; Batt D; Fagin JA
    Clin Cancer Res; 2006 Mar; 12(6):1785-93. PubMed ID: 16551863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia.
    Broccoli A; Terragna C; Nanni L; Martello M; Armuzzi S; Agostinelli C; Morigi A; Casadei B; Pellegrini C; Stefoni V; Sabattini E; Argnani L; Zinzani PL
    Hematol Oncol; 2022 Feb; 40(1):57-62. PubMed ID: 34653277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytes.
    Yap J; Yuan J; Ng WH; Chen GB; Sim YRM; Goh KC; Teo J; Lim TYH; Goay SM; Teo JHJ; Lao Z; Lam P; Sabapathy K; Hu J
    Mol Cancer; 2023 Aug; 22(1):125. PubMed ID: 37543582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRAF(V600E) mutation and the biology of papillary thyroid cancer.
    Frasca F; Nucera C; Pellegriti G; Gangemi P; Attard M; Stella M; Loda M; Vella V; Giordano C; Trimarchi F; Mazzon E; Belfiore A; Vigneri R
    Endocr Relat Cancer; 2008 Mar; 15(1):191-205. PubMed ID: 18310287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Requisite analytic and diagnostic performance characteristics for the clinical detection of BRAF V600E in hairy cell leukemia: a comparison of 2 allele-specific PCR assays.
    Brown NA; Weigelin HC; Bailey N; Laliberte J; Elenitoba-Johnson KS; Lim MS; Betz BL
    Appl Immunohistochem Mol Morphol; 2015 Sep; 23(8):590-600. PubMed ID: 24503706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Molecular and therapeutic advances in Hairy cell leukemia].
    Balsat M; Cornillon J
    Bull Cancer; 2013 Oct; 100(10):1043-7. PubMed ID: 24103785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BRAF V600E mutation does not predict recurrence after long-term follow-up in TNM stage I or II papillary thyroid carcinoma patients.
    Pelttari H; Schalin-Jäntti C; Arola J; Löyttyniemi E; Knuutila S; Välimäki MJ
    APMIS; 2012 May; 120(5):380-6. PubMed ID: 22515292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BRAF mutation detection in hairy cell leukaemia from archival haematolymphoid specimens.
    Thomas C; Amanuel B; Finlayson J; Grieu-Iacopetta F; Spagnolo DV; Erber WN
    Pathology; 2015 Jun; 47(4):349-54. PubMed ID: 25938346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The utility of BRAF V600E mutation-specific antibody VE1 for the diagnosis of hairy cell leukemia.
    Uppal G; Ly V; Wang ZX; Bajaj R; Solomides CC; Banks PM; Medeiros LJ; Peiper SC; Gong JZ
    Am J Clin Pathol; 2015 Jan; 143(1):120-5. PubMed ID: 25511150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BRAF V600E mutation-specific antibody, a sensitive diagnostic marker revealing minimal residual disease in hairy cell leukaemia.
    Akarca AU; Shende VH; Ramsay AD; Diss T; Pane-Foix M; Rizvi H; Calaminici MR; Grogan TM; Linch D; Marafioti T
    Br J Haematol; 2013 Sep; 162(6):848-51. PubMed ID: 23848818
    [No Abstract]   [Full Text] [Related]  

  • 38. BRAF V600E disrupts AZD6244-induced abrogation of negative feedback pathways between extracellular signal-regulated kinase and Raf proteins.
    Friday BB; Yu C; Dy GK; Smith PD; Wang L; Thibodeau SN; Adjei AA
    Cancer Res; 2008 Aug; 68(15):6145-53. PubMed ID: 18676837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BRAF V600E mutation detection in hairy cell leukemia-utility of archival DNA from bone marrow aspirate/imprint smear and amplification refractory mutation system.
    Naseem S; Gupta O; Binota J; Varma N; Varma S; Malhotra P
    Mol Biol Rep; 2020 Jun; 47(6):4365-4372. PubMed ID: 32458259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced B-Raf protein expression is independent of V600E mutant status in thyroid carcinomas.
    Kondo T; Nakazawa T; Murata S; Kurebayashi J; Ezzat S; Asa SL; Katoh R
    Hum Pathol; 2007 Dec; 38(12):1810-8. PubMed ID: 17714762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.